SLGC News and Press, SomaLogic Inc. From 12/26/23

Correspondence Show SomaLogic Failed to Engage with Labcorp – One of the Industry’s Leading Strategics, with a $19 Billion Market Cap – Prior to Pursuing Standard BioTools Deal Madryn Will Continue to Identify Other Strategic Acquirers with Whom the Transaction Commit...

Highlights Current Merger Consideration, Which Assigns No Value and No Premium to SomaLogic’s Desirable Assets, Represents a Material Discount to Company’s Cash Reiterates Combined Entity’s Proforma Capital Structure and Corporate Governance Would Subordinate SomaLo...

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based on Facts, and Madryn Selectively Ignores Risks in a Standalone Strategy and Potential Benefits of the Merger Ur...

Highlights Public Opposition to Proposed Merger from Skye Fund III, a Long-Term SomaLogic Investor Deeply Troubled by Information in Complaint Filed by Company Founder and Chief Technology Officer That Strongly Suggests Merger Proxy Omits Critical Information About Conflicted Merger Proce...

Believes that the Proposed Merger Grossly Undervalues SomaLogic and Ignores its Revolutionary Products, Considerable Cash Position, and Strong Balance Sheet Iterates that SomaLogic can Thrive as a Standalone Enterprise and Does Not Need Standard BioTools to Thrive Expresses Seri...

NEW YORK, NY / ACCESSWIRE / December 20, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Alteryx, Inc. (NYSE:AYX)'s sale...

Encourages SomaLogic Shareholders to Visit www.NoSomaLogicMerger.com to View Presentation and Learn How to Vote “ AGAINST ” the Proposed Merger Madryn Plans to Send a GREEN Proxy Card to SomaLogic Shareholders, and Urges All Shareholders to Vote &...

MONSEY, N.Y., Dec. 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed merger of SomaLogic, Inc. (Nasdaq: SLGC) (“SomaLogic”) with Standard BioTools Inc. in an all-stock transaction. If you remain a SomaLogic share...

Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit Certain Investors and Standard BioTools at the Expense of SomaLogic’s Shareholders ...

2023-12-12 17:17:05 ET SomaLogic Inc. (SLGC) Q3 2023 Earnings Call Transcript SomaLogic rebounds after selloff on news of merger with Standard BioTools Standard BioTools and SomaLogic to combine in an all stock merger Seeking Alpha’s Quant Rating on SomaLo...